Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

NCCN: Multiple myeloma.

A E Traynor¹, S J Noga,

¹Robert H. Lurie Comprehensive Cancer Center of Northwestern University, USA.

Cancer Control : Journal of the Moffitt Cancer Center

|January 5, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Factors associated with second-line triplet therapy in routine care in relapsed/refractory multiple myeloma.

Journal of clinical pharmacy and therapeutics·2017

Same author

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Same author

Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study.

Leukemia·2010

Same author

Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens.

Bone marrow transplantation·2003

Same author

High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases.

Bone marrow transplantation·2003

Same author

The promise of hematopoietic stem cell transplantation for autoimmune diseases.

Bone marrow transplantation·2003

Same journal

Prevalence and Determinants of Female Sexual Dysfunction, and Its Association With Neurotrophic Biomarkers in Gynaecological Cancer Survivors: A Cross-Sectional Study.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Evaluating A Patient-Led Health Literacy Program for People Living With Metastatic Breast Cancer.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Clinical Diagnosis Codes Identify Patients Unlikely to Receive Orders for Fecal Immunochemical Tests.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Passing the Baton: Succession Planning and Mentorship for Cancer Control in Low- and Middle-Income Countries.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Clinical Prediction Models to Guide the Selection of Patients for Colon Capsule Endoscopy Versus Colonoscopy Following FIT-Positive Screening.

Cancer control : journal of the Moffitt Cancer Center·2026

Same journal

Exercise During Chemotherapy Treatment as an Adjuvant Programme in Patients With Lymphoma (EDONOLA): Study Protocol for a Randomised Controlled Trial.

Cancer control : journal of the Moffitt Cancer Center·2026

See all related articles

Multiple myeloma is currently incurable, but treatment can be optimized. Guidelines focus on improving patient quality of life and identifying clinical research opportunities for multiple myeloma (MM) patients.

Area of Science:

Hematology
Oncology
Clinical Therapeutics

Background:

Multiple myeloma (MM) is a hematologic malignancy characterized by uncontrolled plasma cell proliferation.
Current treatments, including chemotherapy and radiation therapy (RT), demonstrate sensitivity but do not achieve a cure for MM.

Framework:

Treatment algorithms integrating published data and clinical expertise are essential for optimizing MM management.
Guidelines should encompass both disease-specific therapies and supportive care strategies to enhance patient quality of life.

Implementation:

Develop evidence-based treatment protocols for multiple myeloma.
Incorporate supportive care measures to mitigate treatment side effects and improve patient well-being.
Prioritize patient enrollment in clinical research protocols when appropriate, given the incurable nature of MM.

Related Experiment Videos

Implications:

Optimized treatment algorithms can improve outcomes and quality of life for patients with multiple myeloma.
A focus on clinical research is crucial for advancing MM therapies towards a potential cure.
Standardized guidelines will aid clinicians in managing this complex hematologic cancer.